Press Releases

November 9, 2022
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
September 21, 2022
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
September 20, 2022
Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing
September 7, 2022
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 7, 2022
Praxis Precision Medicines Provides Updates on Clinical Stage Pediatric Epilepsy Programs
August 8, 2022
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results
August 3, 2022
Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference
June 6, 2022
Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder
May 23, 2022
Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone
Displaying 1 - 10 of 23